Haemostatic abnormalities and lupus anticoagulant activity in patients with Gaucher disease type I.
Barone
R
R
Department of Pediatrics, University of Catania, Italy. rbarone@iol.it
Giuffrida
G
G
Musso
R
R
Carpinteri
G
G
Fiumara
A
A
D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000097:blood; D001779:Blood Coagulation Factors / Q000032:analysis; D005260:Female; D005776:Gaucher Disease / Q000097:blood* / Q000503:physiopathology / Q000628:therapy; D005962:Glucosylceramidase / Q000172:deficiency; D006487:Hemostasis; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D011517:Prothrombin Time
D017153:Antibodies, Anticardiolipin; D017152:Antibodies, Antiphospholipid; D001779:Blood Coagulation Factors; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D016682:Lupus Coagulation Inhibitor; D005962:Glucosylceramidase